why choose us

First received: October 20, 2022

Clinical Trial: Tuberculosis as a Risk Factor for a Worse Outcome Post-Sars-CoV-2 Infection

Study Status: Completed

Recruit Status: Completed

Condition: COVID-19
Tuberculosis
Post-acute COVID-19 Syndrome

Study Type: Observational


Official Title: Tuberculosis as a Risk Factor for a Severe Course and Adverse Long-term Outcome of a Symptomatic Sars-CoV-2 Infection in Johannesburg, South Africa

Brief Summary: This study has two main objectives. First, the clinical characteristics and outcomes of hospitalized patients with symptomatic Covid-19 disease will be compared between persons with a history of past or current TB infection or disease and those, who have had no TB history. The possible impact of an HIV-coinfection will be also addressed in the planned investigations and analysis. Second, the long-term consequences and clinical outcomes of Covid-19 up to 12 months post-infection will be analysed in both groups…

Read more